S2 Episode 2: What Do We Know About Quality of Life and Patient-Reported Outcomes After Transplant and CAR Therapy?

Drs Ann H. Partridge and Stephanie Lee discuss quality of life, patient reported outcomes, and survivorship after transplant and CAR therapy.

Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999930. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Late Effects and Long-Term Follow-Up https://pubmed.ncbi.nlm.nih.gov/31314311/

Long-Term Survivorship Care After CAR-T Cell Therapy https://pubmed.ncbi.nlm.nih.gov/37767547/

Survivorship Care Plan Outcomes for Primary Care Physicians, Cancer Survivors, and Systems: A Scoping Review https://pubmed.ncbi.nlm.nih.gov/29332213/

Late Effects After Chimeric Antigen Receptor T-cell Therapy for Lymphoid Malignancies https://pubmed.ncbi.nlm.nih.gov/33928266/

Cardiovascular Risk Profile of Chimeric Antigen Receptor T-cell Therapy https://pubmed.ncbi.nlm.nih.gov/32351816/

Feasibility and Acceptability of Using a Telehealth Platform to Monitor Cardiovascular Risk Factors in Hematopoietic Cell Transplantation Survivors at Risk for Cardiovascular Disease https://pubmed.ncbi.nlm.nih.gov/32171884/

Understanding and Addressing Disparities in Patients With Hematologic Malignancies: Approaches for Clinicians https://pubmed.ncbi.nlm.nih.gov/33793311/

Late Effects of Severe Acute Graft-versus-Host Disease on Quality of Life, Medical Comorbidities, and Survival https://pubmed.ncbi.nlm.nih.gov/36057421/

Correlation of Patient-Reported Outcomes With Clinical Organ Responses: Data From the Belumosudil Chronic Graft-versus-Host Disease Studies https://pubmed.ncbi.nlm.nih.gov/35781099/